Starting
Initialising…
0%
PPP2R1A
Final classification
VUS
PPP2R1A c.739A>G · p.Thr247Ala
PPP2R1A

NM_014225.5:c.739A>G (p.Thr247Ala) is a missense variant in exon 6 of PPP2R1A, a gene associated with autosomal dominant Houge-Janssens syndrome type 2 (neurodevelopmental disorder). PVS1 is not applicable as this is a missense variant that does not fall into null-variant categories.

Gene
PPP2R1A
Transcript
NM_014225.5
HGVS · transcript:coding
NM_014225.5:c.739A>G
Consequence
N/A
GRCh38
chr19:52213042 A>G
GRCh37
chr19:52716295 A>G
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting; combination = 1 supporting + 1 supporting benign, which maps to VUS.
Classification rationale
PM2 BP4 VUS
PPP2R1A c.739A>G

NM_014225.5:c.739A>G (p.Thr247Ala) is a missense variant in exon 6 of PPP2R1A, a gene associated with autosomal dominant Houge-Janssens syndrome type 2 (neurodevelopmental disorder). PVS1 is not applicable as this is a missense variant that does not fall into null-variant categories.1 This variant is absent from gnomAD v2.1 and gnomAD-Canada, and is present at an extremely low frequency in gnomAD v4.1 (1/1,610,866 alleles; AF = 6.21 × 10⁻⁷), satisfying PM2 at supporting strength.2 Multiple in silico predictors do not support a deleterious effect: REVEL score is 0.285 (below pathogenic threshold of 0.5), BayesDel score is −0.185 (predicted benign), and SpliceAI predicts no splicing impact (max delta = 0.00), satisfying BP4 at supporting strength.3 No variant-specific functional studies, de novo reports, case-control data, segregation data, or ClinVar classifications exist for this variant. No pathogenic comparator variant at the same codon or residue has been identified. All remaining criteria are not met or not applicable.4 The only applicable criteria are PM2_supporting and BP4_supporting, which carry equal and opposite weight. Under the generic ACMG/AMP 2015 combination rules (PMID:25741868), one supporting pathogenic criterion and one supporting benign criterion cancel each other, resulting in a classification of Variant of Uncertain Significance (VUS).5

PM2 + BP4 VUS
Gene diagram · NM_014225.5 · variants mapped to exon structure
PPP2R1A NM_014225.5
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 6.20784e-07; MAF= 0.00006%, 1/1610866 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 8.47936e-07; MAF= 0.00008%, 1/1179334 alleles, homozygotes = 0).
      v2.1
      Absent from gnomAD v2.1.
      🇨🇦 CA
      Absent from gnomAD-Canada v1.0.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      6.2e-05% · 1 / 1,610,866
      0 hom
      European (non-Finnish)
      1 / 1,179,334
      8.5e-05%
      + 9 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD Canada 🇨🇦
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.285. BayesDel score = -0.184741.
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. PPP2R1A encodes a serine/threonine phosphatase that regulates cell growth and division. PPP2R1A is frequently mutated in endometrial and ovarian cance
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      gnomAD-Canada
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots